Purchase Order 75N92023P00333
Award Date 9/17/23
Potential Completion Date 9/16/25
Potential Value $174K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
- This is a firm fixed price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $399,983.62. The contract was not set aside for any specific business size or type. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, will provide a range of sequencing systems, reagents, and services to support NHGRI's genomic research and analysis...
- This firm fixed-price delivery order contract, valued at $5,088, was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract provides for the purchase of Illumina sequencing systems, reagents, and related products to support genomic research and analysis. Illumina has been a long-standing supplier of sequencing goods and services to various federal agencies, including the NIH, CDC, USDA, and VA. The...
- This firm fixed-price delivery order contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and bioinformatics products. The $131,931.29 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related goods and services to support genomic research and analysis. This award is not associated with a set-aside...
- This is a $77,550 firm fixed-price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract does not have a set-aside designation. The contract provides Illumina's advanced DNA and RNA sequencing instruments, reagents, consumables, maintenance services, and bioinformatics...
- This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $490,033.00 and supports the provision of Illumina's sequencing and array-based solutions for genetic and genomic analysis to NHGRI. The contract does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and genomics analysis instruments and reagents, and...
- This firm fixed-price delivery order was awarded to Illumina, Inc. by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian agency. The $9,909.50 contract is not set-aside and provides for the delivery of Illumina's proprietary sequencing systems, reagents, and associated services to support genomic sequencing and analysis research at NHGRI. Illumina has a history of providing similar goods and services to other federal...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, an agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $12,103.44 contract has a completion date of September 29, 2025 and does not utilize a set-aside designation. Illumina provides a range of genomic sequencing platforms, reagents, consumables, and maintenance services to support...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. for $17,149.00. The award is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide sequencing platforms, consumables, and services...
- This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, part of the National Institutes of Health, to Illumina, Inc. The total ceiling value of the contract is $16,851.34 with a final completion date of September 1, 2025. Illumina, a for-profit manufacturer of genomic sequencing and analysis instruments and reagents, has been awarded this contract to provide a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as...